| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CLINICAL STUDY |
Division of Medicine, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia and 1 Garvan Institute of Medical Research, St Vincents Hospital, Darlinghurst, New South Wales 2010, Australia
(Correspondence should be addressed to P Peake; Email: P.Peake{at}unsw.edu.au)
Objective: Little is known of the metabolism of different isoforms of adiponectin. We therefore (a) characterised the size distribution of human adiponectin in relation to gender, body composition and following a challenge with a fat meal or oral glucose in humans, and (b) studied the metabolism of isoforms of human adiponectin in rabbits.
Method: Electrophoresis, blotting and chromatography were used to characterise human adiponectin in 36 healthy subjects, including 15 with at least two first-degree relatives with type 2 diabetes, before and after consumption of a fatty meal or glucose. The metabolism of column-fractionated human adiponectin was studied in rabbits, some of which were coinjected with insulin.
Results: Females had a higher proportion of high molecular weight (HMW) and hexameric adiponectin (P = 0.002 and 0.004 respectively), and a lower proportion of trimers (P < 0.0001) than males. Females also showed a strong negative relationship between body fat measures and the proportion of HMW adiponectin. There were no differences in isoforms between insulin-resistant and -sensitive subjects, or following oral glucose or a fat meal. Adiponectin in rabbits had an extravascular/intravascular ratio of 0.71, and a half-life (T1/2) of 14.3 h. Metabolism was not influenced by insulin or reduction of sulphydryl bonds. HMW and trimeric isoforms had a significantly different T1/2 of 13.0 and 17.5 h respectively (P < 0.05), and these isoforms did not interconvert in vivo.
Conclusions: Human adiponectin is present as trimers, hexamers and HMW forms. Females had a higher proportion and absolute amount of HMW species compared with males, and female, but not male, subjects showed a strong negative relationship between measures of body fat, and the proportion of HMW species. These isoforms did not respond to challenge in man with a fatty meal or oral glucose, and in the rabbit, to injected insulin. HMW adiponectin was more rapidly metabolised than the trimeric form, but both were stable in vivo, and did not interconvert. We conclude that human adiponectin is much longer-lived than is the case with other hormones, a finding with positive implications for the potential to supplement levels of adiponectin in man.
This article has been cited by other articles:
|
|
 |
|
  L. Ibanez, G. Sebastiani, A. Lopez-Bermejo, M. Diaz, M. D. Gomez-Roig, and F. de Zegher Gender Specificity of Body Adiposity and Circulating Adiponectin, Visfatin, Insulin, and Insulin Growth Factor-I at Term Birth: Relation to Prenatal Growth J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2774 - 2778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Neumeier, J. Weigert, R. Buettner, J. Wanninger, A. Schaffler, A. M. Muller, S. Killian, S. Sauerbruch, F. Schlachetzki, A. Steinbrecher, et al. Detection of adiponectin in cerebrospinal fluid in humans Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E965 - E969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W Peake, J. T Hughes, Y. Shen, and J. A Charlesworth Glycosylation of human adiponectin affects its conformation and stability J. Mol. Endocrinol., July 1, 2007; 39(1): 45 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Semple, N. H. Halberg, K. Burling, M. A. Soos, T. Schraw, J. Luan, E. K. Cochran, D. B. Dunger, N. J. Wareham, P. E. Scherer, et al. Paradoxical Elevation of High-Molecular Weight Adiponectin in Acquired Extreme Insulin Resistance Due to Insulin Receptor Antibodies Diabetes, June 1, 2007; 56(6): 1712 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shibata, K. Sato, M. Kumada, Y. Izumiya, M. Sonoda, S. Kihara, N. Ouchi, and K. Walsh Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment Cardiovasc Res, June 1, 2007; 74(3): 471 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Santaniemi, Y A. Kesaniemi, and O. Ukkola Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur. J. Endocrinol., November 1, 2006; 155(5): 745 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Snijder, R. J. Heine, J. C. Seidell, L. M. Bouter, C. D.A. Stehouwer, G. Nijpels, T. Funahashi, Y. Matsuzawa, I. Shimomura, and J. M. Dekker Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care, November 1, 2006; 29(11): 2498 - 2503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Retnakaran, A. J.G. Hanley, and B. Zinman Does Hypoadiponectinemia Explain the Increased Risk of Diabetes and Cardiovascular Disease in South Asians? Diabetes Care, August 1, 2006; 29(8): 1950 - 1954. [Full Text] [PDF]
|
|
|
|
|
|
C. G. Schalkwijk, N. Chaturvedi, M. T. Schram, J. H. Fuller, C. D. A. Stehouwer, and the EURODIAB Prospective Complications Study Group Adiponectin Is Inversely Associated with Renal Function in Type 1 Diabetic Patients J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 129 - 135. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
